Special feature—Late effects consensus conference
Late effects of radiation on the eye and ocular adnexa

https://doi.org/10.1016/0360-3016(95)00062-4Get rights and content

Abstract

A clinically useful classification system is suggested that can be used in prospective trials to evluate the effects of radiation on the visual system. We review radiation-induced pathophysiological and clinical changes of the various ocular structures as well as dose-response data and management of ocular complications. The rationale for the classification scheme chosen is also discussed.

References (92)

  • P.J. Fitzpatrick et al.

    Basal and squamous cell carcinoma of the eyelids and their treatment by radiotherapy

    Int. J. Rad. Onc. Biol. Phys.

    (1984)
  • J. Guy et al.

    Hyberbaric oxygen in the treatment of radiation-induced optic neuropathy

    Ophthalmol.

    (1986)
  • A.R. Irvine et al.

    Radiation retinopathy as an experimental model for ischemic proliferative retinopathy and rubeosis iridis

    Am. J. Ophthalmol.

    (1987)
  • B. Jereb et al.

    Radiation therapy of conjunctival and orbital lymphoid tumors

    Int. J. Rad. Onc. Biol. Phys.

    (1984)
  • D.M. Ju et al.

    Effect of radiation on the development of facial structures in retinoblatoma cases

    Am. J. Surg.

    (1963)
  • J.L. Kinyoun et al.

    Photocoagulation treatment of radiation retinopathy

    Am. J. Ophthalmol.

    (1988)
  • L.B. Kline et al.

    Radiation optic neuropathy

    Ophthalmol.

    (1985)
  • D.L. Larson et al.

    Long-term effects of radiotherapy in childhood and adolescence

    Am. J. Surg.

    (1990)
  • P.F. Lopez et al.

    Bone marrow transplant retinopathy

    Am. J. Ophthalmol.

    (1991)
  • A.A. Lovato et al.

    The effect of silicone nasolacrimal intubation on epiphora after helium ion irradiation of uveal melanomas

    Am. J. Ophthalmol.

    (1989)
  • F.D. MacKenzie et al.

    Recurrence rate and complications after beta irradiation for pterygia

    Ophthalmol.

    (1991)
  • M.L. Miller et al.

    Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy

    Am. J. Ophthalmol.

    (1991)
  • K.J. Minehan et al.

    Local control and complications after radiation therapy for primary orbital lymphoma: A case for low-dose treatment

    Int. J. Rad. Onc. Biol. Phys.

    (1991)
  • J.D. Roarty et al.

    Incidence of second neoplasms in patients with bilateral retinoblastoma

    Ophthalmol.

    (1988)
  • D. Roden et al.

    Delayed radiation injury to the retrobulbar optic nerves and chiasm

    Ophthalmol.

    (1990)
  • R.H. Sagerman et al.

    Radiotherapy for nasolacrimal tract epithelial cancer

    Int. J. Radiat. Oncol. Biol. Phys.

    (1994)
  • C.A. Shields et al.

    Plaque radiotherapy in the management of retinoblastoma: Use as a primary and secondary treatment

    Ophthalmol.

    (1993)
  • W.M. Wara et al.

    Radiation retinopathy

    Int. J. Rad. Onc. Biol. Phys.

    (1979)
  • C. Zimmerman et al.

    Magnetic resonance imaging of radiation optic neuropathy

    Am. J. Ophthalmol.

    (1990)
  • B.E. Amendola et al.

    Radiotherapy of retinoblastoma: A review of 63 children treated with different irradiation techniques

    Cancer

    (1990)
  • W.M.K. Amoaku et al.

    Early ultrastructural changes after low-dose X-irradiation in the retina of the rat

    Eye

    (1989)
  • D. Bardenstein et al.

    Ocular toxicity

  • A. Birch-Hirschfeld

    Die wirkung der rontgen-und radiumstrahlen auf das auge

    Graefes Arch. Ophthalmol.

    (1904)
  • G.T. Boozalis et al.

    Subretinal neovascularization from the retina in radiation retinopathy

    Retina

    (1987)
  • H. Chalupecky

    Ueber die wirkung der rontgenstrahlen auf das Auge und die haut

    Zentralbl Augenheilkd

    (1897)
  • R.C. Chan et al.

    Effects of irradiation on the eye

    Radiology

    (1976)
  • D.H. Char

    Clinical ocular oncology

    (1989)
  • D.H. Char et al.

    Five-year follow-up of helium ion therapy for uveal melanoma

    Arch. Ophthalmol.

    (1990)
  • P.R. Chaudhuri et al.

    Treatment of radiation retinopathy

    Br.J. Ophthalmol.

    (1981)
  • D.G. Cogan et al.

    Clinical and pathologic characteristics of radiation cataract

    Arch. Ophthalmol.

    (1952)
  • G. Dean et al.

    Increased risk of cataract in patients receiving radiotherapy to the eye: A pilot study

    Br. J. Radiol.

    (1988)
  • J.A. del Regato

    Milestones in therapeutic radiology

  • D.J. Derkinderen et al.

    Nonocular cancer in hereditary retinoblastoma survivors and relatives

    Ophthalmol. Peds. Genet.

    (1987)
  • G.J. Draper et al.

    Second primary neoplasms in patients with retinoblastoma

    Br. J. Cancer

    (1986)
  • P.R. Egbert et al.

    Posterior ocular abnormalities after irradiation for retinoblatoma: A histopathological study

    Br. J. Ophthalmol.

    (1980)
  • Cited by (166)

    • Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus

      2018, Radiotherapy and Oncology
      Citation Excerpt :

      The lens is a biconvex structure in the eye that helps to refract light. Any stimulus causing posterior migration and proliferation of the lens epithelial cells reduces the lens clarity, causing a cataract, and often results in some degree of visual loss [32]. The CTCAE v4.0 distinguishes 4 grades of cataract based on visual acuity ranging from asymptomatic (grade 1) to complete blindness (20/200 or worse) in the affected eye (grade 4) [12].

    • Dry Eye Syndrome After Proton Therapy of Ocular Melanomas

      2017, International Journal of Radiation Oncology Biology Physics
      Citation Excerpt :

      Such data are increasingly relevant to cancer centers as PT facilities are expanding rapidly worldwide. The International Dry Eye Workshop defines DES as a disease affecting tears and ocular surface, resulting in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface (12-15). Although mild to moderate DES is often successfully managed with supportive therapy, severe DES (sDES) may result in irreversible corneal damage with compromised vision, severe pain, and eye loss.

    View all citing articles on Scopus
    View full text